# FDA WARNING_LETTER - Namita A. Goyal, M.D. - June 23, 2023

Source: https://www.globalkeysolutions.net/records/warning_letter/namita-a-goyal-md/10e2319c-97cc-49b6-ae50-effb34334ca6

> FDA WARNING_LETTER for Namita A. Goyal, M.D. on June 23, 2023. Product: Biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Namita A. Goyal, M.D.
- Inspection Date: 2023-06-23
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Officers

- [Director](https://www.globalkeysolutions.net/people/melissa-j-mendoza/681d7777-4f19-4ecc-b31d-3272cb275c77)
- [ Director, Bioresearch Monitoring Division (West) and FDA Delegate to the OECD Working Party on GLPs](https://www.globalkeysolutions.net/people/eric-s-pittman/878b3087-615d-4e1f-9a9f-0649b46b817b)

Company: https://www.globalkeysolutions.net/companies/namita-a-goyal-md/90ce31f2-692a-4779-ac98-4d39419085ff

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d